SESN share price trailing 3-Y Beta is 3.01, making a possible higher RoR yet also presenting more risk. Profit to share is at -$0.67 over last 12 months. Share prices decreased -39.98 (%) (YTD) for a decline of -0.98 (%) over the last twelve months. Stock prices are -75.65 (%) from year high of $3.50 and 11.88 with the 52 Week lowest stock price at $0.76. Overall the stocks consensus estimates are 0 – out of 5, stock experts rate these shares a buy.
Sesen Bio, Inc. (SESN) could see increases of 488.24 (%) within the next year to $5price as 12-month high target. For a 488.24 (%) increase compared to the stocks current price. The 12-month median targeted valuation forecaste price by stock experts is $4.5, possible return at 429.41 (%) as share prices closed at $0.85 on Monday, January 07. The bottom estimated targeted valuation for shares are $1 an increase upwards of 17.65 (%) than SESN’s stock price today.
Stocks for Sesen Bio, Inc. have risen on 3 earnings reactions and increasing 0.11 (%) on earnings reports.
In Sesen Bio, Inc. (NASDAQ:SESN) we see trading started at 02/14/2017. Mccabe John J decided to sell 1.4 thousand of this stock priced $2.1. For a value of $2.94 thousand. Following the transaction, the Chief Financial Officer was at 5.93 thousand of this stock. Shares then dropped -59.52 (%) post-sale. Then at 09/28/2016, Celniker Abbie, Director, sold 10.03 thousand of this stock at a share price of $3. Taking out 30.09 thousand of this stock from the directors portfolio and shares hit a -71.67 (%) fall in price. 409.92 thousand of this stock in the insiders stock portfolio.
On 09/23/2016, 10% Owner Flagship Ventures Fund 2007, L decided to sell stock of $1.4 million. Selling at $3.16 reducing 443.42 thousand of this stock from their trading account. Then shares made a -73.1 (%) drop. They now have 1.83 million shares left in their portfolio. Flagship Ventures Fund 2007, L, who performs the 10% Owner job, sold 386.34 thousand of this stock for $1.43 million. They sold on the 09/21/2016 at an averaged $3.69 share price. Stock prices then dropped -76.96 (%). Flagship Ventures Fund 2007, L has now 1.83 million SESN shares in the company at $1.56 million following the sale.
The Company’s stock prices are at $0.83. With support at $0.82. Up to now SESN shares trade higher than this price, investors are OK for now. RSI went to 32.38 which seems OK. Yet if stock prices go to $0.82 more sell-offs are forecaste. However if shares go to $0.88 then we could see trading at a $0.92 price.
Company stock of Sesen Bio, Inc. (SESN) have Profit-Earnings Ratio at 6.84 (x) 12 month earnings reports. This market SESN is in has a median Profit-Earnings Ratio at 69.71. The Profit-Earnings Ratio dipped to 21.95X while rising to 21.95 over the 5-year span.